# GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery

> **NCT01728844** · NA · COMPLETED · sponsor: **Sunstar Americas** · enrollment: 88 (actual)

## Conditions studied

- Alveolar Bone Loss
- Periodontal Diseases

## Interventions

- **DEVICE:** beta-tricalcium phosphate alone
- **DEVICE:** GFeBGS 0.1%
- **DEVICE:** GFeBGS 0.3%
- **DEVICE:** GFeBGS 0.4%

## Key facts

- **NCT ID:** NCT01728844
- **Lead sponsor:** Sunstar Americas
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728844, "GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01728844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*